Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9616 | 1070 | 44.4 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
989 | 10020 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C MYB | Author keyword | 98 | 53% | 12% | 128 |
2 | B MYB | Author keyword | 67 | 72% | 5% | 53 |
3 | V MYB | Author keyword | 21 | 71% | 2% | 17 |
4 | MYB | Author keyword | 18 | 22% | 7% | 73 |
5 | V MYB ONCOGENE | Author keyword | 11 | 100% | 1% | 6 |
6 | MYBL2 | Author keyword | 8 | 60% | 1% | 9 |
7 | A MYB | Author keyword | 7 | 67% | 1% | 6 |
8 | C MYB PROTEIN | Author keyword | 6 | 80% | 0% | 4 |
9 | MYB ONCOGENE | Author keyword | 6 | 100% | 0% | 4 |
10 | MYB DNA BINDING DOMAIN | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C MYB | 98 | 53% | 12% | 128 | Search C+MYB | Search C+MYB |
2 | B MYB | 67 | 72% | 5% | 53 | Search B+MYB | Search B+MYB |
3 | V MYB | 21 | 71% | 2% | 17 | Search V+MYB | Search V+MYB |
4 | MYB | 18 | 22% | 7% | 73 | Search MYB | Search MYB |
5 | V MYB ONCOGENE | 11 | 100% | 1% | 6 | Search V+MYB+ONCOGENE | Search V+MYB+ONCOGENE |
6 | MYBL2 | 8 | 60% | 1% | 9 | Search MYBL2 | Search MYBL2 |
7 | A MYB | 7 | 67% | 1% | 6 | Search A+MYB | Search A+MYB |
8 | C MYB PROTEIN | 6 | 80% | 0% | 4 | Search C+MYB+PROTEIN | Search C+MYB+PROTEIN |
9 | MYB ONCOGENE | 6 | 100% | 0% | 4 | Search MYB+ONCOGENE | Search MYB+ONCOGENE |
10 | MYB DNA BINDING DOMAIN | 4 | 67% | 0% | 4 | Search MYB+DNA+BINDING+DOMAIN | Search MYB+DNA+BINDING+DOMAIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | V MYB | 289 | 72% | 21% | 225 |
2 | A MYB | 131 | 74% | 9% | 96 |
3 | C MYB | 91 | 28% | 26% | 274 |
4 | B MYB | 78 | 51% | 10% | 109 |
5 | GENE V MYB | 77 | 96% | 2% | 24 |
6 | CELLULAR PROGENITOR | 76 | 86% | 4% | 38 |
7 | AVIAN MYELOBLASTOSIS VIRUS | 66 | 57% | 7% | 77 |
8 | MIM 1 GENE | 64 | 75% | 4% | 47 |
9 | HELIX RELATED MOTIF | 27 | 74% | 2% | 20 |
10 | ONCOGENE C MYB | 26 | 87% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MYB function in normal and cancer cells | 2008 | 160 | 156 | 71% |
The myb gene family in cell growth, differentiation and apoptosis | 1999 | 297 | 199 | 71% |
The DREAM complex: master coordinator of cell cycle-dependent gene expression | 2013 | 34 | 139 | 32% |
Role and potential for therapeutic targeting of MYB in leukemia | 2013 | 10 | 115 | 64% |
One billion years of Myb | 1996 | 192 | 166 | 69% |
Transformation by v-Myb | 1999 | 80 | 128 | 80% |
Cell cycle regulation by the B-Myb transcription factor | 2003 | 58 | 99 | 67% |
Critical roles for c-Myb in hematopoietic progenitor cells | 2008 | 40 | 105 | 60% |
MYB - AN OLD ONCOPROTEIN WITH NEW ROLES | 1995 | 73 | 68 | 79% |
B-Myb, Cancer, Senescence, and MicroRNAs | 2011 | 12 | 43 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHONBUK MED | 4 | 75% | 0.3% | 3 |
2 | ORAL BIO SCI | 3 | 60% | 0.3% | 3 |
3 | MOL IMMUNOHEMATOL | 2 | 38% | 0.5% | 5 |
4 | ILBIT | 2 | 67% | 0.2% | 2 |
5 | STATE BIOTHER Y STEM CELL BIOL | 2 | 67% | 0.2% | 2 |
6 | KECK GENOM OURCE | 1 | 100% | 0.2% | 2 |
7 | DIFFERENTIAT TRANSCRIPT | 1 | 19% | 0.5% | 5 |
8 | SECT VIROL CELL BIOL | 1 | 17% | 0.5% | 5 |
9 | AFFY S TRANSCRIPTOME | 1 | 50% | 0.1% | 1 |
10 | CANC IMMUNOL METAB MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163876 | V ERB B//V ERBB//ACUTE RETROVIRUS |
2 | 0.0000093727 | MSSP//C MYC PROTEIN//ONCOGENE RESEARCH |
3 | 0.0000069684 | ETS 1//ETS DOMAIN//ETS FAMILY |
4 | 0.0000056674 | PDCD4//PROGRAMMED CELL DEATH 4//PROGRAMMED CELL DEATH 4 PDCD4 |
5 | 0.0000047603 | PU1//SPI 1 PU1//SFPI1 PU1 |
6 | 0.0000044222 | C FES//FER KINASE//FPS FES |
7 | 0.0000037636 | E2F//P107//P130 |
8 | 0.0000037532 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
9 | 0.0000035935 | FBXW7//FBW7//HCDC4 |
10 | 0.0000035067 | AVIAN LEUKOSIS VIRUS//AVIAN LEUKOSIS VIRUS SUBGROUP J//MYELOID LEUKOSIS |